4D-QSAR Study of 17β-Hydroxysteroid Dehydrogenase Type 3 Inhibitors

被引:1
作者
Martins, Jodo Paulo A. [1 ]
de Melo, Eduardo B. [2 ]
机构
[1] Univ Fed Minas Gerais, Dept Quim, BR-31270901 Belo Horizonte, MG, Brazil
[2] Univ Estadual Oeste Parana, Lab Quim Med & Ambiental TeOr, BR-85819110 Cascavel, PR, Brazil
关键词
prostate cancer; 17; beta-HSD3; computer-aided drug design; Web-4D-QSAR; DIFFERENT VALIDATION CRITERIA; REAL EXTERNAL PREDICTIVITY; PROSTATE-CANCER; QSAR MODELS; MULTIDIMENSIONAL QSAR; LQTA-QSAR; REGRESSION; QSPR; DISCOVERY; SELECTION;
D O I
10.21577/0103-5053.20190052
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Prostate cancer is one of the most common form of cancer among men, and its incidence has been increasing progressively. Since the prostate depends on androgenic hormones to regulate its growth and development, interference with androgenic biosynthesis are important to control the disease. Thus, in this work, a 4D-quantitative structure-activity relationship (QSAR) receptor independent study was carried out using the Laboratorio de Quimiometria Teorica e Aplicada (LQTA)-QSAR approach and the new tool Web-4D-QSAR with a set of benzylidene oxazolidinedione and thiazolidinedione inhibitor of the 17 beta-hydroxysteroid dehydrogenase type 3. The obtained model is robust, free from chance correlation, and with good predictability in all tests performed. In addition to this result, a good mecanistic interpretation related to the binding with the biological target could be traced, which strengthens its potential application in virtual screening and design of new inhibitors of the studied enzyme with the possibility of use in the pharmacological treatment of prostate cancer.
引用
收藏
页码:1548 / 1557
页数:10
相关论文
共 50 条
[41]   Steroidal lactones as inhibitors of 17β-hydroxysteroid dehydrogenase type 5: Chemical synthesis, enzyme inhibitory activity, and assessment of estrogenic and androgenic activities [J].
Bydal, Patrick ;
Luu-The, Van ;
Labrie, Fernand ;
Poirier, Donald .
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2009, 44 (02) :632-644
[42]   Differential expression of type 2 3α/type 5 17β-hydroxysteroid dehydrogenase (AKR1C3) in tumors of the central nervous system [J].
Park, Aubrey L. ;
Lin, Hsueh-Kung ;
Yang, Qing ;
Sing, Chor Wing ;
Fan, Michael ;
Mapstone, Timothy B. ;
Gross, Naina L. ;
Gumerlock, Mary K. ;
Martin, Michael D. ;
Rabb, Craig H. ;
Fung, Kar-Ming .
INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2010, 3 (08) :743-754
[43]   A- and D-Ring Structural Modifications of an Androsterone Derivative Inhibiting 17β-Hydroxysteroid Dehydrogenase Type 3: Chemical Synthesis and Structure-Activity Relationships [J].
Cortes-Benitez, Francisco ;
Roy, Jenny ;
Perreault, Martin ;
Maltais, Rene ;
Poirier, Donald .
JOURNAL OF MEDICINAL CHEMISTRY, 2019, 62 (15) :7070-7088
[44]   Expression of 17β-hydroxysteroid dehydrogenase type 2 is associated with some clinicopathological features in gastric cancer [J].
Frycz, Bartosz Adam ;
Murawa, Dawid ;
Borejsza-Wysocki, Maciej ;
Marciniak, Ryszard ;
Murawa, Pawel ;
Drews, Michal ;
Jagodzinski, Pawel Piotr .
BIOMEDICINE & PHARMACOTHERAPY, 2015, 70 :24-27
[45]   Synthesis, Biochemical Evaluation and Rationalisation of a Series of (3-O-Sulfonate) Derivatives of Estrone (E1) as Probes of the Active Site of Type 3 of the 17β-Hydroxysteroid Dehydrogenase (17β-HSD) Family of Enzymes [J].
Akbarzadeh, Mohsen ;
Olusanjo, Moniola S. ;
Ahmed, Sabbir .
LETTERS IN DRUG DESIGN & DISCOVERY, 2012, 9 (01) :69-76
[46]   Quinoxalinones Based Aldose Reductase Inhibitors: 2D and 3D-QSAR Analysis [J].
Masand, Vijay H. ;
Elsayed, Nahed N. ;
Thakur, Sumersingh D. ;
Gawhale, Nandkishor ;
Rathore, Mithilesh M. .
MOLECULAR INFORMATICS, 2019, 38 (8-9)
[47]   3D-QSAR and molecular docking study of LRRK2 kinase inhibitors by CoMFA and CoMSIA methods [J].
Pourbasheer, E. ;
Aalizadeh, R. .
SAR AND QSAR IN ENVIRONMENTAL RESEARCH, 2016, 27 (05) :385-407
[48]   Synthesis and evaluation of thiadiazole derivatives as inhibitors of 11β-hydroxysteroid dehydrogenase type 1 [J].
Pradaux-Caggiano, Fabienne ;
Su, Xiangdong ;
Vicker, Nigel ;
Thomas, Mark P. ;
Smithen, Deborah ;
Halem, Heather A. ;
Culler, Michael D. ;
Potter, Barry V. L. .
MEDCHEMCOMM, 2012, 3 (09) :1117-1124
[49]   4D-QSAR, ADMET properties, and molecular dynamics simulations for designing N-substituted urea/thioureas as human glutaminyl cyclase inhibitors [J].
Wei, Chaochun ;
Zhang, Haolin ;
Niu, Lexuan ;
Zhong, Qidi ;
Yan, Hong ;
Wang, Juan .
COMPUTATIONAL BIOLOGY AND CHEMISTRY, 2024, 112
[50]   17β-hydroxysteroid dehydrogenase type 11 (Pan1b) expression in human prostate cancer [J].
Nakamura, Y. ;
Suzuki, T. ;
Arai, Y. ;
Sasano, H. .
NEOPLASMA, 2009, 56 (04) :317-320